Earnings Call Summary | NUFARM LTD(NUFMF.US) Q2 2024 Earnings Conference
Earnings Call Summary | NUFARM LTD(NUFMF.US) Q2 2024 Earnings Conference
The following is a summary of the Nufarm Limited (NUFMF) Q2 2024 Earnings Call Transcript:
以下是Nufarm有限公司（NUFMF）2024年第二季度業績會電話交流摘要：
Financial Performance:
金融業績：
Nufarm reported underlying EBITDA of $217 million and statutory NPAT of $49 million for H1 of 2024.
The company predicts EBITDA of between $350 million and $390 million for FY 2024.
An interim dividend of $0.04 per share was declared.
Despite higher average working capital, commitment remains towards efficient capital use, with a predicted return of average net working capital to the target range.
Expectations for underlying EBITDA between $350 million and $390 million in FY 2024 represent a 16% reduction from FY '23
The projection for strong growth in H2 '24, with the guidance midpoint indicating EBITDA growth of 25% YoY.
Nufarm報告了2024年上半年2.17億美元的基礎EBITDA和4900萬美元的法定NPAT。
公司預測FY 2024的EBITDA在3.5億美元至3.9億美元之間。
宣佈每股支付0.04美元的中期股息。
儘管平均營運資本較高，但承諾仍然是要高效使用資本，預計平均淨營運資本將回歸目標區間。
預計FY 2024的基礎EBITDA在3.5億至3.9億美元之間，比FY'23減少16％。
預計H2'24強勁增長，指導中點表明EBITDA同比增長25％。
Business Progress:
業務進展：
Significant progress made in reducing inventory, now 20% lower YoY.
Continued support for Omega-3 and Carinata plantings with expected revenue growth in 2025. Reaffirmed 2024 Omega-3 revenue projection of $50 million to $70 million.
Growth plans include geo-expansion of Carinata planting and continued discussions with potential Nutriterra segment partners in the U.S.
The targeted Crop Protection business revenue is between $3.8 billion and $3.9 billion by FY '26.
A strong future is anticipated for the biofuels platform, expanding in Southern U.S.A., Argentina, Brazil, France, and Spain.
Through 2025 and '26, Omega-3 production is expected to be scaled, and a strengthening of position in phenoxy herbicides and new product introductions is aimed for.
Completed strategic actions include factory closures, performance improvement programs, portfolio acquisitions, and a state-of-the-art formulation facility launch.
Nufarm plans to achieve its 2026 targets with a roughly 20% price recovery and contributions from NPIs.
The company continues to monitor the supply chain situation in China for their Herbicide production, anticipating that restocking and replenishment needs should cause a price increase as demand increases.
大量減少庫存，現在相比去年同期下降20％。
繼續支持Omega-3和Carinata種植業務，預計2025年營收增長。重申2024年Omega-3的營收預測爲5000萬至7000萬美元。
增長計劃包括Carinata種植業務的地理擴張，以及與美國潛在Nutriterra部門合作伙伴的繼續討論。
在FY'26之前，農作物保護業務的目標營收爲38億至39億美元。
預計生物燃料平台未來將強勁增長，擴展至美國南部、阿根廷、巴西、法國和西班牙。
通過2025年和2026年，Omega-3產量預計將擴大，併力爭在苯氧基除草劑領域加強地位並推出新產品。
已完成的戰略行動包括工廠關閉、績效改進計劃、產品組合收購和一家最先進的配方設施的推出。
Nufarm計劃通過20％左右的價格恢復和NPI的貢獻來實現2026年的目標。
公司繼續監控中國供應鏈情況，因爲預計補貨需求將導致需求增加，從而導致價格上漲。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。